Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asthma trial of steroid responsiveness and alternative therapies in non-eosinophilic asthma
ACTRN12606000488505Phase 4Completed
- Sponsor
- University of Otago
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of fluticasone, formoterol, theophylline and clarithromycin in asthma, non-eosinophilic asthma (NEA) and eosinophilic asthma (EA), sponsored by University of Otago. Primary endpoint: Asthma control. Started Apr 2007; status: completed.
02
Drugs
fluticasoneformoteroltheophyllineclarithromycin
03
Conditions
asthmanon-eosinophilic asthma (NEA)eosinophilic asthma (EA)
Beyond the preview
Go deeper on ACTRN12606000488505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000488505.